MedWatch

Danish biotech company ready to launch ”red wine-pill” in Europe

The Danish biotech company Fluxome Sciences A/S is now ready with the European launch of a food supplement, the substance of which is known as the health-giving property of red wine. Meanwhile the company is on the verge of raising DKK 100 million.

Foto: Jesper Dudal / Stock.Xchng

Following an EU-approval of the company’s food supplement ingredient, popularly known as the “red wine-pill”, the Danish biotech company Fluxome Sciences A/S is ready to conquer the global market.

The information comes from Fluxome’s acting CEO, Jarne Elleholm, who is a partner in the Danish state investment fund, Vækstfonden. He was instated, when the contract with former CEO Steen Andersen was terminated in the fall of 2011. However, the company is still looking for a more permanent solution for the post. Vækstfonden is one of Fluxome’s investors.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier